Equities

BioSig Technologies Inc

BSGM:PKC

BioSig Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.3501
  • Today's Change-0.020 / -5.38%
  • Shares traded32.72k
  • 1 Year change-97.08%
  • Beta0.6363
Data delayed at least 15 minutes, as of Jun 28 2024 20:46 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

  • Revenue in USD (TTM)27.00k
  • Net income in USD-25.25m
  • Incorporated2011
  • Employees4.00
  • Location
    BioSig Technologies Inc55 Greens Farms RoadWESTPORT 06880United StatesUSA
  • Phone+1 (203) 409-5444
  • Fax+1 (302) 645-1280
  • Websitehttps://www.biosig.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arch Therapeutics Inc130.55k-8.43m4.27m8.00------32.68-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Hawkeye Systems Inc0.00-804.18k4.33m44.00---------0.1186-0.11860.00-0.290.00-------66.07-330.11-----------218.49---2.7810.45------4.85------
Predictive Oncology Inc1.96m-14.78m4.35m34.00--1.06--2.22-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Pressure Biosciences Inc1.98m-35.20m4.39m15.00------2.22-1.65-1.650.0885-0.92611.292.388.86131,850.70-1,916.46-872.30----40.4332.33-1,482.20-1,066.480.0136-0.595----14.37-4.25-97.72------
ReShape Lifesciences Inc8.34m-10.92m4.64m31.00--1.02--0.5572-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
Catheter Precision Inc439.00k-6.85m4.74m14.00--0.2559--10.80-1.03-1.030.06592.450.01150.37595.7431,357.14-17.89---19.64--94.31---1,559.68--0.8047--0.004--3,057.14---165.67------
ADM Tronics Unlimited Inc2.85m-716.86k4.74m7.00--4.30--1.67-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Bioelectronics Corp1.61m-289.82k4.94m9.00------3.07-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Encision Inc6.87m-448.00k4.94m31.00--2.25--0.7198-0.0381-0.03810.58350.18631.641.967.84221,520.00-10.69-1.07-14.05-1.4650.5452.27-6.52-0.6131.08-6.220.1123---4.17-3.44-393.90--12.89--
BioSig Technologies Inc27.00k-25.25m5.20m4.00------192.48-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
Venus Concept Inc73.30m-37.39m5.20m304.00------0.071-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Sonendo Inc40.19m-57.74m5.34m216.00--0.2177--0.1329-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
VirExit Technologies Inc0.00-1.80m5.45m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Guided Therapeutics Inc82.00k-3.23m5.64m4.00------68.72-0.0623-0.06230.0016-0.07210.03740.090411.7120,500.00-137.80-136.13----32.9329.39-3,685.37-3,666.670.1138-11.13----653.8511.4524.40------
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
Data as of Jun 28 2024. Currency figures normalised to BioSig Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

2.94%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 May 2024129.03k0.91%
PFG Investments LLCas of 31 Mar 2024106.15k0.75%
Geode Capital Management LLCas of 30 Apr 202453.23k0.38%
Jane Street Capital LLCas of 31 Mar 202443.82k0.31%
HRT Financial LLCas of 31 Mar 202426.33k0.19%
BlackRock Fund Advisorsas of 06 Jun 202413.35k0.09%
Commonwealth Equity Services LLCas of 31 Mar 202412.50k0.09%
Virtu Americas LLCas of 31 Mar 202411.78k0.08%
Truist Bank (Private Banking)as of 31 Mar 202411.23k0.08%
Tower Research Capital LLCas of 31 Mar 20247.05k0.05%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.